These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9274131)

  • 21. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
    Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
    Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
    Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
    J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scintimammography in the diagnosis of breast cancer.
    Clifford EJ; Lugo-Zamudio C
    Am J Surg; 1996 Nov; 172(5):483-6. PubMed ID: 8942549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decision analysis: MIBI imaging of nonpalpable breast abnormalities.
    Hillner BE
    J Nucl Med; 1997 Nov; 38(11):1772-8. PubMed ID: 9374352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
    Tiling R; Kessler M; Untch M; Sommer H; Linke R; Brinkbäumer K; Hahn K
    Onkologie; 2003 Feb; 26(1):27-31. PubMed ID: 12624514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
    J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Mirzaei S; Knoll P; Lipp RW; Köhn H
    J Nucl Med; 2000 Feb; 41(2):390-1. PubMed ID: 10688127
    [No Abstract]   [Full Text] [Related]  

  • 28. (99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study.
    Khalkhali I; Baum JK; Villanueva-Meyer J; Edell SL; Hanelin LG; Lugo CE; Taillefer R; Freeman LM; Neal CE; Scheff AM; Connolly JL; Schnitt SJ; Houlihan MJ; Sampalis JS; Haber SB
    Radiology; 2002 Jan; 222(1):149-55. PubMed ID: 11799940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occult breast cancer detection with technetium-99m-sestamibi: a case report.
    Park YH; Ferrante J; Robinson RE; Arvay K
    J Nucl Med Technol; 1999 Dec; 27(4):298-300. PubMed ID: 10646550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of 99mTC-Sestamibi in the diagnosis of breast cancer. Report on 100 cases].
    Fliquete Peris MV; Giménez Climent J; Vázquez Forner C; Más Arcas C; Vázquez Albaladejo C
    Rev Esp Med Nucl; 1999 Dec; 18(6):436-41. PubMed ID: 10611570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
    Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
    J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer.
    Melloul M; Paz A; Ohana G; Laver O; Michalevich D; Koren R; Wolloch Y; Gal R
    J Nucl Med; 1999 Mar; 40(3):376-80. PubMed ID: 10086698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue-specific effects on uptake of 99mTc-sestamibi by breast lesions: a targeted analysis of false scintigraphic diagnoses.
    Tiling R; Stephan K; Sommer H; Shabani N; Linke R; Hahn K
    J Nucl Med; 2004 Nov; 45(11):1822-8. PubMed ID: 15534050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
    Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
    Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer detection with sestamibi-Tc-99m and Tl-201 radionuclides in patients with non conclusive mammography.
    Alonso JC; Soriano A; Zarca MA; Guerra P; Alcazar R; Molino C
    Anticancer Res; 1997; 17(3B):1661-5. PubMed ID: 9179214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tc-99m sestamibi exam finds niche in breast Dx.
    Chen EM; Khalkhali I; Cutrone JA; Diggles LE; Mishkin F
    Diagn Imaging (San Franc); 1997 Aug; 19(8):61-5. PubMed ID: 10169379
    [No Abstract]   [Full Text] [Related]  

  • 37. Tc-99m-MIBI scintimammography; SPECT versus planar imaging.
    Aziz A; Hashmi R; Ogawa Y; Hayashi K
    Cancer Biother Radiopharm; 1999 Dec; 14(6):495-500. PubMed ID: 10850336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions.
    Tiling R; Sommer H; Pechmann M; Moser R; Kress K; Pfluger T; Tatsch K; Hahn K
    J Nucl Med; 1997 Jan; 38(1):58-62. PubMed ID: 8998151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tc-99m sestamibi scintimammography: where is it now?
    Schillaci O; Scopinaro F
    Cancer Biother Radiopharm; 1999 Dec; 14(6):417-22. PubMed ID: 10850328
    [No Abstract]   [Full Text] [Related]  

  • 40. Scintimammography with 99mTc-sestamibi as a complementary diagnostic technique.
    Torkzad MR
    Acta Radiol; 2001 May; 42(3):345. PubMed ID: 11419397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.